Sensorion SA (ALSEN)

Currency in EUR
0.3100
-0.0020(-0.64%)
Real-time Data·
ALSEN Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
ALSEN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.30800.3160
52 wk Range
0.15440.9700
Key Statistics
Prev. Close
0.312
Open
0.31
Day's Range
0.308-0.316
52 wk Range
0.1544-0.97
Volume
54.65K
Average Volume (3m)
752.93K
1-Year Change
-53.57%
Book Value / Share
0.24
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ALSEN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
2.1250
Upside
+585.48%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Sensorion SA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Sensorion SA Company Profile

Sensorion SA, a biotechnology company, develops drug candidates for the treatment of inner ear disorders in France. The company’s product portfolio includes SENS-401 SSNHL, which has completed Phase 2b clinical trial for the treatment of Sudden Sensorineural Hearing Loss; SENS-401 CIO that is in Phase 2a clinical trial for the treatment of Cisplatin-Induced Ototoxicity; and SENS-401 Cochlear, which is in Phase 2a clinical which is an orally available small molecule protecting and preserving inner ear tissue from damage, responsible for hearing impairment. It is also developing OTOF-GT (SENS-501), a gene therapy development program that has completed Phase 1/2 clinical trial to restore hearing in people living with Otoferlin deficiency; and GJB2-GT, a gene therapy development program, which is in pre-clinical trial to restore hearing in people living with hearing loss due to mutations in the GJB2 gene. The company was incorporated in 2009 and is headquartered in Montpellier, France.

Compare ALSEN to Peers and Sector

Metrics to compare
ALSEN
Peers
Sector
Relationship
P/E Ratio
−3.6x−2.5x−0.5x
PEG Ratio
−0.070.030.00
Price/Book
1.3x1.3x2.6x
Price / LTM Sales
14.1x4.8x3.2x
Upside (Analyst Target)
-180.8%44.1%
Fair Value Upside
Unlock9.3%6.2%Unlock

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 2.1250
(+585.48% Upside)

Earnings

Latest Release
May 28, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ALSEN Income Statement

People Also Watch

3.4450
ALTBG
+6.00%
1.36
ALEXP
-1.45%
7.540
ALBDM
-1.05%
5.9800
ALENT
-3.86%

FAQ

What Stock Exchange Does Sensorion SA Trade On?

Sensorion SA is listed and trades on the Paris Stock Exchange stock exchange.

What Is the Stock Symbol for Sensorion SA?

The stock symbol for Sensorion SA is "ALSEN."

What Is the Sensorion SA Market Cap?

As of today, Sensorion SA market cap is 92.55M.

What Is Sensorion SA's Earnings Per Share (TTM)?

The Sensorion SA EPS (TTM) is -0.09.

When Is the Next Sensorion SA Earnings Date?

Sensorion SA will release its next earnings report on 16 Sept 2025.

From a Technical Analysis Perspective, Is ALSEN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Sensorion SA Stock Split?

Sensorion SA has split 0 times.

How Many Employees Does Sensorion SA Have?

Sensorion SA has 63 employees.

What is the current trading status of Sensorion SA (ALSEN)?

As of 22 Jul 2025, Sensorion SA (ALSEN) is trading at a price of 0.31, with a previous close of 0.31. The stock has fluctuated within a day range of 0.31 to 0.32, while its 52-week range spans from 0.15 to 0.97.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.